336 related articles for article (PubMed ID: 36336884)
1. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
[TBL] [Abstract][Full Text] [Related]
2. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
[TBL] [Abstract][Full Text] [Related]
4. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
5. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
[TBL] [Abstract][Full Text] [Related]
8. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
Front Immunol; 2021; 12():769204. PubMed ID: 34880865
[TBL] [Abstract][Full Text] [Related]
10. The alteration of N6-methyladenosine (m6A) modification at the transcriptome-wide level in response of heat stress in bovine mammary epithelial cells.
Qi Y; Zhang Y; Zhang J; Wang J; Li Q
BMC Genomics; 2022 Dec; 23(1):829. PubMed ID: 36517742
[TBL] [Abstract][Full Text] [Related]
11. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
[TBL] [Abstract][Full Text] [Related]
13. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
14. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
Ren S; Xiao Y; Yang L; Hu Y
Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers.
Ramasamy D; Thippannah M; Maharajan HRP; Balaiah M; Seshadri RA; Kodous AS; Herceg Z; Mehta A; Rao AKDM; Mani S
Mol Biol Rep; 2024 Feb; 51(1):299. PubMed ID: 38345740
[TBL] [Abstract][Full Text] [Related]
16. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
17. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs.
Steponaitis G; Stakaitis R; Valiulyte I; Krusnauskas R; Dragunaite R; Urbanavičiūtė R; Tamasauskas A; Skiriute D
Sci Rep; 2022 Mar; 12(1):5431. PubMed ID: 35361860
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
[TBL] [Abstract][Full Text] [Related]
20. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
Yin L; Ma C; Hou S; Ma X
Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
